Assuming the possible interaction between the pro-inflammatory TLR2 and 4 pathways andthe anti-inflammatory PPARγ pathway, we investigated the expression of the negativeregulator PPARγ in the colonic mucosa of IBS patients. Here, TLR2 is linked to irritable bowel syndrome.